Phase 2 study of pembrolizumab-based combination therapy in patients with microsatellite instability-high or mismatch repair-deficient stage IV colorectal cancer

Basit Öğe Kaydı
dc.authorid0000-0003-3211-8516
dc.contributor.authorAndre, T.
dc.contributor.authorSposetti, C.
dc.contributor.authorGümüş, M.
dc.contributor.authorAhn, J. Bae
dc.contributor.authorWyrwicz, L.
dc.contributor.authorKwiatkowski, M.
dc.contributor.authorKim, J.
dc.date.accessioned2025-05-10T19:48:32Z
dc.date.issued2022
dc.departmentİstanbul Medeniyet Üniversitesi
dc.description.abstract[No abstract available]
dc.description.sponsorshipMerck Sharp Dohme Corp.
dc.description.sponsorshipMerck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA.
dc.identifier.doi10.1016/j.annonc.2022.04.118
dc.identifier.endpageS257
dc.identifier.issn0923-7534
dc.identifier.issn1569-8041
dc.identifier.scopusqualityQ1
dc.identifier.startpageS256
dc.identifier.urihttps://doi.org/10.1016/j.annonc.2022.04.118
dc.identifier.urihttps://hdl.handle.net/20.500.14730/11737
dc.identifier.volume33
dc.identifier.wosWOS:000823826500041
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.language.isoen
dc.publisherElsevier
dc.relation.ispartofAnnals of Oncology
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_WOS_20250302
dc.titlePhase 2 study of pembrolizumab-based combination therapy in patients with microsatellite instability-high or mismatch repair-deficient stage IV colorectal cancer
dc.typeConference Object

Dosyalar

Orijinal paket

Listeleniyor 1 - 1 / 1
Küçük Resim
İsim:
11737.pdf
Boyut:
126.9 KB
Biçim:
Adobe Portable Document Format
İndir

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu